Table 2.
The relationship of AIS and control groups with LDL subclasses
| Patients (n=110) | Controls (n=60) | p | AIS subtypes | |||
|---|---|---|---|---|---|---|
| CI (n=40) | LAA (n=40) | LI (n=30) | ||||
| LDL-1 (mg/dL) | 34.6±10.6 | 33.8±8.1 | 0.602 | 32.7±9.8 | 36.2±10.4 | 34.8±12.0 |
| LDL-2 (mg/dL) | 24.9±10.1 | 15.6±9.5 | <0.001 | 24.6±11.1* | 24.4±9.2* | 24.5±13.1* |
| LDL-3 (mg/dL) | 5.5±6.7 | 2.3±3.3 | <0.001 | 5.1±6.2* | 4.8±5.7* | 6.9±8.5* |
| LDL-4 (mg/dL) | 0.9±2.9 | 0.04±0.2 | 0.011 | 0.9±3.3 | 0.9±3.1* | 1.0±2.0* |
LDL, low density lipoprotein; CI, cardioembolic infarct; LAA, large artery atherosclerosis; LI, lacunar infarct.
*
p <0.05 versus control group